v3.26.1
Condensed Consolidated Statements of Operations - USD ($)
$ in Thousands
3 Months Ended 6 Months Ended
Jun. 30, 2026
Jun. 30, 2025
Jun. 30, 2026
Jun. 30, 2025
Revenues:        
Total revenue $ 44,745 $ 12,455 $ 65,491 $ 21,181
Operating expenses:        
Cost of sales 2,996 1,702 4,315 2,787
Research and development 100,754 91,940 181,902 164,683
Selling, general and administrative 51,547 45,869 99,851 87,396
Total operating expenses 155,297 139,511 286,068 254,866
Loss from operations (110,552) (127,056) (220,577) (233,685)
Interest income, net 9,730 14,513 20,525 30,600
Other income, net 119 523 238 1,776
Net loss $ (100,703) $ (112,020) $ (199,814) $ (201,309)
Net loss per share - basic (in usd per share) $ (1.69) $ (1.93) $ (3.38) $ (3.49)
Net loss per share - diluted (in usd per share) $ (1.69) $ (1.93) $ (3.38) $ (3.49)
Weighted-average number of common shares used in computing net loss per share – basic (in shares) 59,488,871 57,932,576 59,137,508 57,697,193
Weighted-average number of common shares used in computing net loss per share – diluted (in shares) 59,488,871 57,932,576 59,137,508 57,697,193
Product revenue, net        
Revenues:        
Total revenue $ 44,745 $ 12,455 $ 65,491 $ 21,181